摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5 | 156470-23-4

中文名称
——
中文别名
——
英文名称
(2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5
英文别名
——
(2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5化学式
CAS
156470-23-4
化学式
C29H34O6
mdl
——
分子量
478.585
InChiKey
JCKGDWMAAIEHKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    646.0±50.0 °C(predicted)
  • 密度:
    1.119±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.07
  • 重原子数:
    35.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    66.38
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    (2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5碘甲烷 在 potassium hydride 作用下, 生成 (2-(1,1-diphenyl-2-oxapropyl)-1,3-xylylene)-18-crown-5
    参考文献:
    名称:
    Intra-annular reactions of the (1,3-xylylene)-18-crown-5 system: synthesis and crystal structure of [2-(bromomagnesio)-1,3-xylylene]-18-crown-5, [2-(bromomercurio)-1,3-xylylene]-18-crown-5 and bis[(1,3-xylylene-18-crown-5)-2-yl]mercury
    摘要:
    The Grignard compound [2-(bromomagnesio)-1,3-xylylene]-18-crown-5 (4) was prepared from the aryllithium compound (2-lithio-1,3-xylylene)-18-crown-5 (9) and magnesium bromide. The crystal structure of 4 shows that it crystallizes without solvent and is coordinatively saturated (distorted octahedral) by complexation of the magnesium with four of the five crown ether oxygens.The 1:1 reaction of 9 with HgBr2 yielded the corresponding organomercury compound [2-(bromomercurio)-1,3-xylylene]-18-crown-5 (10), which crystallizes without solvent. Its crystal structure reveals that intramolecular Hg-O coordination occurs with two of the five oxygens, and only weak interaction with a third crown ether oxygen. Reaction of 10 with metallic magnesium lead to the symmetric compound bis[(1,3-xylylene-18-crown-5)-2-yl]mercury (11). The centrosymmetric crystal structure of 11 shows that the mercury is intramolecularly coordinated with only four of the ten oxygens; the mercury atom is completely shielded by the crown ether rings. This shielding is probably the reason for the failure to bring about reaction of 11 with magnesium to give the corresponding diarylmagnesium compound.The crown ether Grignard 4 was treated with deuterium oxide, chlorotrimethylstannane, iodine and benzophenone to give the products (2-D-1,3-xylylene)-18-crown-5 (14a), (2-trimethylstannyl-1,3-xylylene)-18-crown-5) (15), (2-iodo-1,3-xylylene)-18-crown-5 (16) and 2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5 (17) (the latter being converted into its methyl ether (2-(1,1-diphenyl-2-oxapropyl)-1,3-xylylene)-18-crown-5 (17a) for identification), respectively. The lithium compound 9 was treated with benzophenone, chlorotrimethylgermane, chlorodiphenyrphosphine and 4,4'-dimethoxybenzophenone to give intra-annularly substituted crown ether derivatives 17, (2-trimethylgermyl-1,3-xylylene)-18-crown-5 (18), (2-diphenylphosphinyl-1,3-xylylene)-18-crown-5 (19) (the latter undergoing slow oxidation to (2-oxodiphenylphosphinyl-1,3-xylylene)-18-crown-5 (20)) and (2-(4,4'-dimethoxy-diphenylhydroxymethyl)-1,3-xylylene)-18-crown-5 (21) (which was converted under acidic conditions to (2-[(4-methoxyphenyl)(4'oxo-2',5'-cyclohexylidene)methyl]-1,3-xylylene)-18-crown-5 (22)), respectively.
    DOI:
    10.1016/0022-328x(93)83392-9
  • 作为产物:
    描述:
    (2-lithio-1,3-xylylene)-18-crown-5 在 magnesium bromide 作用下, 以 四氢呋喃 为溶剂, 反应 5.0h, 生成 (2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5
    参考文献:
    名称:
    Intra-annular reactions of the (1,3-xylylene)-18-crown-5 system: synthesis and crystal structure of [2-(bromomagnesio)-1,3-xylylene]-18-crown-5, [2-(bromomercurio)-1,3-xylylene]-18-crown-5 and bis[(1,3-xylylene-18-crown-5)-2-yl]mercury
    摘要:
    The Grignard compound [2-(bromomagnesio)-1,3-xylylene]-18-crown-5 (4) was prepared from the aryllithium compound (2-lithio-1,3-xylylene)-18-crown-5 (9) and magnesium bromide. The crystal structure of 4 shows that it crystallizes without solvent and is coordinatively saturated (distorted octahedral) by complexation of the magnesium with four of the five crown ether oxygens.The 1:1 reaction of 9 with HgBr2 yielded the corresponding organomercury compound [2-(bromomercurio)-1,3-xylylene]-18-crown-5 (10), which crystallizes without solvent. Its crystal structure reveals that intramolecular Hg-O coordination occurs with two of the five oxygens, and only weak interaction with a third crown ether oxygen. Reaction of 10 with metallic magnesium lead to the symmetric compound bis[(1,3-xylylene-18-crown-5)-2-yl]mercury (11). The centrosymmetric crystal structure of 11 shows that the mercury is intramolecularly coordinated with only four of the ten oxygens; the mercury atom is completely shielded by the crown ether rings. This shielding is probably the reason for the failure to bring about reaction of 11 with magnesium to give the corresponding diarylmagnesium compound.The crown ether Grignard 4 was treated with deuterium oxide, chlorotrimethylstannane, iodine and benzophenone to give the products (2-D-1,3-xylylene)-18-crown-5 (14a), (2-trimethylstannyl-1,3-xylylene)-18-crown-5) (15), (2-iodo-1,3-xylylene)-18-crown-5 (16) and 2-(diphenylhydroxy)methyl-1,3-xylylene)-18-crown-5 (17) (the latter being converted into its methyl ether (2-(1,1-diphenyl-2-oxapropyl)-1,3-xylylene)-18-crown-5 (17a) for identification), respectively. The lithium compound 9 was treated with benzophenone, chlorotrimethylgermane, chlorodiphenyrphosphine and 4,4'-dimethoxybenzophenone to give intra-annularly substituted crown ether derivatives 17, (2-trimethylgermyl-1,3-xylylene)-18-crown-5 (18), (2-diphenylphosphinyl-1,3-xylylene)-18-crown-5 (19) (the latter undergoing slow oxidation to (2-oxodiphenylphosphinyl-1,3-xylylene)-18-crown-5 (20)) and (2-(4,4'-dimethoxy-diphenylhydroxymethyl)-1,3-xylylene)-18-crown-5 (21) (which was converted under acidic conditions to (2-[(4-methoxyphenyl)(4'oxo-2',5'-cyclohexylidene)methyl]-1,3-xylylene)-18-crown-5 (22)), respectively.
    DOI:
    10.1016/0022-328x(93)83392-9
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫